Effects of castration and androgen replacement on erectile function in a rabbit model.
We investigated, in a rabbit model, the effects of castration and testosterone replacement on: 1) the hemodynamics of the corpus cavernosum; 2) alpha-1 adrenergic receptor protein expression; 3) neural NO synthase protein expression and activity; 4) phosphodiesterase type 5 activity; and 5) trabecular smooth muscle/connective tissue balance. One week after bilateral orchiectomy, animals were treated for 7 days with vehicle alone, testosterone, or estradiol. Intact control animals received vehicle only. Systemic arterial blood and intracavernosal pressures (ICP) were measured in each animal before and after electrical stimulation of the cavernosal nerve. Alpha1-adrenergic receptor protein expression was determined by ligand binding studies. NO synthase expression and activity were determined by Western blot analyses and conversion of L-arginine to citrulline, respectively. Phosphodiesterase type 5 activity was determined by hydrolysis of guanosine 3',5'-cyclic monophosphate (cGMP) in tissue extracts in the absence or presence of 100 nM sildenafil. Smooth muscle content was assessed by Masson's trichrome staining and computer-assisted histomorphometry. Castration significantly reduced ICP, but it did not alter systemic arterial blood pressure during stimulation of the cavernosal nerve. Testosterone, but not estradiol, treatment prevented the effects of castration and restored ICP to values similar to those obtained in intact animals. Castration reduced expression of alpha1-adrenergic receptor, and this reduction was prevented or reversed by testosterone replacement. Neural NO synthase protein expression and total activity were not altered significantly by castration or after testosterone replacement. However, phosphodiesterase type 5 activity increased in castrated animals treated with testosterone. Castration significantly reduced trabecular smooth muscle content, and this reduction was restored by testosterone (but not estradiol) treatment. The results of this study demonstrate that androgen deprivation alters the functional responses and structure of erectile tissue.
Traish
A M
AM
Department of Urology, Boston University School of Medicine, Massachusetts 02118, USA. atraish@bu.edu
Park
K
K
Dhir
V
V
Kim
N N
NN
Moreland
R B
RB
Goldstein
I
I
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism; D000818:Animals; D001120:Arginine / Q000378:metabolism; D001794:Blood Pressure; D015153:Blotting, Western; D002956:Citrulline / Q000378:metabolism; D004558:Electric Stimulation; D004958:Estradiol / Q000494:pharmacology; D006439:Hemodynamics; D020249:Hormone Replacement Therapy; D008297:Male; D008954:Models, Biological; D009130:Muscle, Smooth / Q000033:anatomy & histology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D009919:Orchiectomy; D010410:Penile Erection / Q000187:drug effects / Q000502:physiology*; D010413:Penis / Q000033:anatomy & histology / Q000098:blood supply / Q000294:innervation; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism; D013739:Testosterone / Q000494:pharmacology*
D011942:Receptors, Adrenergic, alpha; D002956:Citrulline; D013739:Testosterone; D004958:Estradiol; D001120:Arginine; D019001:Nitric Oxide Synthase; D015106:3',5'-Cyclic-GMP Phosphodiesterases